Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

Abstract

ObjectivesEvaluation of long-term safety of rituximab in rheumatoid arthritis (RA).MethodsPooled observed case analysis of data from patients with moderate-to-severe, active RA treated with rituximab in a global clinical trial programme.ResultsAs...